HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Clinical trials for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive 'Smart Bomb' targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing a new radioactive drug that seeks out a protein called Nectin-4 found on many cancer cells. The drug delivers a dose of radiation directly to the tumor, aiming to destroy it while sparing healthy tissue. About 150 adults with advanced bladder, br…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Radioactive tracer could spot hidden breast cancer tumors
Diagnosis Recruiting nowThis early-phase trial is testing a new radioactive imaging agent called 68Ga-R10602 in 36 people with hormone receptor-positive breast cancer that has come back or spread. The agent is designed to light up tumors on PET/CT scans. The main goals are to check safety and see how we…
Matched conditions: HORMONE RECEPTOR POSITIVE BREAST ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Radionetics Oncology • Aim: Diagnosis
Last updated Jun 23, 2026 11:54 UTC